Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
EU makes 1 billion-euro bet on Gilead's COVID drug before trial results
BRUSSELS (Reuters) - The European Union has agreed to pay more than 1 billion euros ($1.
Canaan Closes $800 Million VC Fund for Life Sciences and Technology
Venture capital firm Canaan Partners closed on a new fund, it’s twelfth, raising $800 million to invest.
Prenatal cannabis exposure linked to cognitive deficits, altered behavior
Regular cannabis exposure in rats during pregnancy may cause their offspring to have long-term cognitive deficiencies, asocial behavior, and anxiety later in adulthood.
China's Sinopharm offers experimental COVID-19 vaccines to students
(Reuters) - A division of Chinese state-run Sinopharm Group Co Ltd that is developing two COVID-19 vaccines is offering them for free to Chinese students going abroad for higher studies, the W...
EdiGene Gets $67 Million Infusion to Bring Gene Editing to the Clinic
EdiGene raked in approximately $67 million in a series B financing round to further their genome-editing pipeline and expand the team.
Pfizer Gets FDA OK to Test Adolescents in COVID-19 Vaccine Trial
To date, all the major clinical trials of vaccines against COVID-19 have been in adults.
Dyno Therapeutics Strikes AAV Deal with Roche Worth up to $1.8 Billion
This morning, Cambridge, Mass.
Six Indian drug companies to set up a large pharma cluster in Mexico
Hyderabad.
Dutch researchers report first death from COVID-19 reinfection
An elderly woman in the Netherlands has died after getting COVID-19 a second time, researchers reported on Monday.
Takeda group begins manufacturing COVID-19 plasma treatment ahead of approval
NEW YORK (Reuters) - The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether i...
GAO details ongoing problems with FDA's lab safety oversight
The US Government Accounting Office (GAO) found that many elements of an effort to improve laboratory safety at the Food and Drug Administration (FDA) have not been met, over three yea...
New Zealand signs deal with Pfizer, BioNTech for COVID-19 vaccine
SYDNEY (Reuters) - The New Zealand government signed a deal on Monday to buy 1.
15
16
17
18
19
20
21
22
23
